157 related articles for article (PubMed ID: 29135615)
1. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.
Keating NL; Huskamp HA; Schrag D; McWilliams JM; McNeil BJ; Landon BE; Chernew ME; Normand ST
Med Care; 2018 Jan; 56(1):69-77. PubMed ID: 29135615
[TBL] [Abstract][Full Text] [Related]
2. Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.
Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
JAMA Netw Open; 2020 Jan; 3(1):e1918586. PubMed ID: 31899533
[TBL] [Abstract][Full Text] [Related]
3. Critical Lessons From High-Value Oncology Practices.
Blayney DW; Simon MK; Podtschaske B; Ramsey S; Shyu M; Lindquist C; Milstein A
JAMA Oncol; 2018 Feb; 4(2):164-171. PubMed ID: 29145584
[TBL] [Abstract][Full Text] [Related]
4. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States.
Erie JC; Barkmeier AJ; Hodge DO; Mahr MA
Ophthalmology; 2016 Jun; 123(6):1257-62. PubMed ID: 26976701
[TBL] [Abstract][Full Text] [Related]
5. Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.
Donohue JM; Normand SL; Horvitz-Lennon M; Men A; Berndt ER; Huskamp HA
J Ment Health Policy Econ; 2016 Jun; 19(2):69-78. PubMed ID: 27453458
[TBL] [Abstract][Full Text] [Related]
6. Variation in Physician Spending and Association With Patient Outcomes.
Tsugawa Y; Jha AK; Newhouse JP; Zaslavsky AM; Jena AB
JAMA Intern Med; 2017 May; 177(5):675-682. PubMed ID: 28288254
[TBL] [Abstract][Full Text] [Related]
7. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
8. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Adams JR; Elting LS; Lyman GH; George JN; Lembersky BC; Armitage JO; Demetri GD; Bennett CL
Am J Med; 2004 Jan; 116(1):28-34. PubMed ID: 14706663
[TBL] [Abstract][Full Text] [Related]
9. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
Bynum J; Song Y; Fisher E
J Am Geriatr Soc; 2010 Apr; 58(4):674-80. PubMed ID: 20345867
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
11. The impact of integration on outpatient chemotherapy use and spending in Medicare.
Jung J; Feldman R; Kalidindi Y
Health Econ; 2019 Apr; 28(4):517-528. PubMed ID: 30695812
[TBL] [Abstract][Full Text] [Related]
12. Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients.
Dean EB; Johnson P; Bond AM
JAMA Netw Open; 2021 Jan; 4(1):e2034776. PubMed ID: 33502485
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Physician Variation in Provision of Low-Value Services.
Schwartz AL; Jena AB; Zaslavsky AM; McWilliams JM
JAMA Intern Med; 2019 Jan; 179(1):16-25. PubMed ID: 30508010
[TBL] [Abstract][Full Text] [Related]
14. Variation in Practice Patterns and Reimbursements Between Female and Male Urologists for Medicare Beneficiaries.
Nam CS; Mehta A; Hammett J; Kim FY; Filson CP
JAMA Netw Open; 2019 Aug; 2(8):e198956. PubMed ID: 31397864
[TBL] [Abstract][Full Text] [Related]
15. Opioid Prescribing in the 2016 Medicare Fee-for-Service Population.
Maciejewski ML; Zepel L; Hale SL; Wang V; Diamantidis CJ; Blaz JW; Olin S; Wilson-Frederick SM; James CV; Smith VA
J Am Geriatr Soc; 2021 Feb; 69(2):485-493. PubMed ID: 33216957
[TBL] [Abstract][Full Text] [Related]
16. Treating age-related macular degeneration: comparing the use of two drugs among medicare and veterans affairs populations.
Pershing S; Pal Chee C; Asch SM; Baker LC; Boothroyd D; Wagner TH; Bundorf MK
Health Aff (Millwood); 2015 Feb; 34(2):229-38. PubMed ID: 25646102
[TBL] [Abstract][Full Text] [Related]
17. What Is the Value of Undergoing Surgery for Spinal Metastases at Dedicated Cancer Centers?
Malik AT; Khan SN; Voskuil RT; Alexander JH; Drain JP; Scharschmidt TJ
Clin Orthop Relat Res; 2021 Jun; 479(6):1311-1319. PubMed ID: 33543875
[TBL] [Abstract][Full Text] [Related]
18. Low-Value Service Use in Provider Organizations.
Schwartz AL; Zaslavsky AM; Landon BE; Chernew ME; McWilliams JM
Health Serv Res; 2018 Feb; 53(1):87-119. PubMed ID: 27861838
[TBL] [Abstract][Full Text] [Related]
19. The influence of bevacizumab on the costs of ovarian cancer treatment in routine clinical practice.
Vuorinen RK; Luukkaala TH; Mäenpää JU
Acta Oncol; 2020 Apr; 59(4):453-457. PubMed ID: 31920123
[No Abstract] [Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
